BR, P., HN, P., JB, J., ES, L., JS, K., GY, C., . . . IS, L. (2024). Efficacy and safety of drospirenone 2 mg/17β-estradiol 1 mg hormone therapy in Korean postmenopausal women. Obstetrics & gynecology science, 67(4), 430. https://doi.org/10.5468/ogs.2017.60.2.213.e1
Chicago Style (17th ed.) CitationBR, Park, Park HN, Jung JB, Lee ES, Kim JS, Choi GY, Lee JJ, and Lee IS. "Efficacy and Safety of Drospirenone 2 Mg/17β-estradiol 1 Mg Hormone Therapy in Korean Postmenopausal Women." Obstetrics & Gynecology Science 67, no. 4 (2024): 430. https://doi.org/10.5468/ogs.2017.60.2.213.e1.
MLA (9th ed.) CitationBR, Park, et al. "Efficacy and Safety of Drospirenone 2 Mg/17β-estradiol 1 Mg Hormone Therapy in Korean Postmenopausal Women." Obstetrics & Gynecology Science, vol. 67, no. 4, 2024, p. 430, https://doi.org/10.5468/ogs.2017.60.2.213.e1.